Key facts
- Pascal (Medical Supplies)’s last known valuation is $9.4M (Jun 2025).
- It has raised $2.6M; the latest was Seed Round ($2.6M) in Jun 2025.
- Notable investors include VentureWell.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Pascal (Medical Supplies)
- ·The full record, as it builds
Funding rounds
No funding rounds for Pascal (Medical Supplies) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pascal (Medical Supplies)
Developer of a synthetic polymer hydrogel designed to seal surgical and traumatic leaks and deliver drugs directly to surgical sites. The company's technology is intended for applications in orthopedic, spine, and neurosurgery procedures, enabling patients to benefit from safer and more effective treatments.
- Sector
- Healthcare
- HQ
- Richmond, VA, United States
- Founded
- 2022
- Website
- pascalmed.com/
- Ownership
- Privately Held (backing)
Pascal (Medical Supplies) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pascal (Medical Supplies) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pascal (Medical Supplies) in its N-PORT filings yet. We sweep new filings monthly.